Clinical Trial Update: The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD [NA]

View source ↗

Summary

This document is a clinical trial update examining the safety and efficacy of sildenafil for severe post-capillary pulmonary hypertension caused by COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: COPD, Pulmonary Hypertension | NA | Status: UNKNOWN